RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rohto Pharmaceutical Co - Stock

Rohto Pharmaceutical Co Market capitalization 2024

Rohto Pharmaceutical Co Market capitalization

742.45 B JPY

Ticker

4527.T

ISIN

JP3982400008

WKN

858075

In 2024, Rohto Pharmaceutical Co's market cap stood at 742.45 B JPY, a 7.29% increase from the 692 B JPY market cap in the previous year.

The Rohto Pharmaceutical Co Market capitalization history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)NET INCOME (undefined JPY)
2027e36043,6942.6
2026e335.2946,9139.18
2025e305.851,4334.67
2024270.8458,0730.94
2023238.6657,5826.38
2022199.6558,1921.13
2021181.2959,0016.74
2020188.3360,6315.41
2019183.5859,669.8
2018171.7458,819.29
2017154.659,0910.01
2016167.0259,739.1
2015151.7759,558.63
2014143.8259,738.95
2013129.1559,128.09
2012120.2958,498.18
2011115.4759,027.97
2010113.4358,877.77
2009110.6158,966.14
2008108.1359,137.53
200795.6261,086.62
200685.8562,426.48
200573.3363,615.44

Rohto Pharmaceutical Co Aktienanalyse

What does Rohto Pharmaceutical Co do?

Rohto Pharmaceutical Co Ltd is a leading Japanese company in the pharmaceutical and cosmetic products industry, founded in 1899. The company was originally established as a small company to manufacture herbal medicine before undergoing several mergers and acquisitions to become the company we know today. Rohto Pharmaceutical's business model focuses on developing and marketing innovative products for health and beauty. The company has a global reputation for its high-quality products that undergo stringent testing to ensure they are safe and effective. Rohto Pharmaceutical has various business divisions. One of the main areas is the pharmaceutical division, which manufactures medications for various ailments, including ophthalmology, pain relief, and skincare. Another important business area is Rohto Pharmaceutical's cosmetics division, which offers a wide range of facial care products, sunscreen, and whitening products. The company is known for its lotions and emulsions that are based on high-quality ingredients such as vitamin C, hyaluronic acid, and collagen. Over the years, Rohto Pharmaceutical has also launched several groundbreaking products. For example, the company developed the world's first eye drop product for dry eyes. Another groundbreaking invention by Rohto is the invention of menthol cooling effects in eye drops, which are intended to provide a refreshing sensation in the eyes. Rohto Pharmaceutical has developed innovative technologies and production facilities with cleanroom laboratories for pharmaceutical and cosmetic products. The company's technological advancements also include the development of hybrid companies that combine the competencies of pharmacists and cosmetologists, facilitating the development of products for the beauty and health sectors. Although Rohto Pharmaceutical has focused its efforts on the Japanese market, the company has also opened branches in other countries, including the USA, Europe, and Asia. As a result, Rohto offers a wide range of products such as menthol spray, sunscreen, and eye drops that are sold worldwide. Conclusion: Rohto Pharmaceutical is a leading provider of pharmaceutical and cosmetic products. The company has built its reputation based on its innovative products, stringent quality controls, and groundbreaking technologies. Rohto Pharmaceutical has a vision that encompasses "building health, creating beauty, and making life easier." By dividing its business into various divisions, the company is able to offer a wide range of health and beauty products to meet customer needs. Rohto Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Rohto Pharmaceutical Co's Market Capitalization

Rohto Pharmaceutical Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Rohto Pharmaceutical Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Rohto Pharmaceutical Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Rohto Pharmaceutical Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Rohto Pharmaceutical Co stock

What is the current Rohto Pharmaceutical Co market capitalization?

The current market capitalization of Rohto Pharmaceutical Co is 742.45 B JPY.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Rohto Pharmaceutical Co.

How has the market capitalization of Rohto Pharmaceutical Co developed in recent years?

The market capitalization of Rohto Pharmaceutical Co has increased/decreased by 7.29% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Rohto Pharmaceutical Co?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Rohto Pharmaceutical Co?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Rohto Pharmaceutical Co have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Rohto Pharmaceutical Co pay?

Over the past 12 months, Rohto Pharmaceutical Co paid a dividend of 30 JPY . This corresponds to a dividend yield of about 0.92 %. For the coming 12 months, Rohto Pharmaceutical Co is expected to pay a dividend of 32.04 JPY.

What is the dividend yield of Rohto Pharmaceutical Co?

The current dividend yield of Rohto Pharmaceutical Co is 0.92 %.

When does Rohto Pharmaceutical Co pay dividends?

Rohto Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Rohto Pharmaceutical Co?

Rohto Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Rohto Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 32.04 JPY are expected. This corresponds to a dividend yield of 0.99 %.

In which sector is Rohto Pharmaceutical Co located?

Rohto Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Rohto Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rohto Pharmaceutical Co from 12/1/2024 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Rohto Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Rohto Pharmaceutical Co in the year 2023?

In the year 2023, Rohto Pharmaceutical Co distributed 24 JPY as dividends.

In which currency does Rohto Pharmaceutical Co pay out the dividend?

The dividends of Rohto Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rohto Pharmaceutical Co

Our stock analysis for Rohto Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rohto Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.